For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221121:nRSU0382Ha&default-theme=true
RNS Number : 0382H Investec PLC 21 November 2022
Investec Limited Investec plc
Incorporated in the Republic of South Africa Incorporated in England and Wales
Registration number 1925/002833/06
Registration number 3633621
JSE share code: INL
LSE share code: INVP
JSE hybrid code: INPR JSE share code: INP
ISIN: GB00B17BBQ50
JSE debt code: INLV
LEI: 2138007Z3U5GWDN3MY22
NSX share code: IVD
BSE share code: INVESTEC
ISIN: ZAE000081949
LEI: 213800CU7SM6O4UWOZ70
Investec Limited intention to purchase Investec plc ordinary shares and to repurchase Investec Limited ordinary shares
Shareholders are referred to the interim results for the period ended 30
September 2022 released on 17 November 2022, wherein shareholders were
advised that Investec Limited has approved a proposed share purchase and share
buy-back programme, in conjunction with the initial share purchase programme
previously announced, of up to a total of R7 billion (c.£350 million),
pursuant to which Investec Limited would purchase Investec plc ordinary shares
and would repurchase Investec Limited ordinary shares. Investec anticipates
that this programme will be executed over the next 18 months subject to market
conditions (collectively, "the Programme").
As part of the continued execution of the Programme, Investec Limited has
entered into a mandate with Investec Markets Limited (the "Broker") to conduct
an on-market purchase of Investec plc ordinary shares and the repurchase of
Investec Limited ordinary shares ("the Shares") ("the Mandate"). The Broker
will act as principal and will purchase the Shares, on the Johannesburg Stock
Exchange, the London Stock Exchange or other trading venues in the United
Kingdom and South Africa on which the Shares are listed. The Shares will then
be sold on by the Broker to Investec Limited.
The Broker shall not purchase shares or securities relating to the Shares on
trading venues based in the United States of America or knowingly from any
persons located in the United States of America, nor shall it knowingly
undertake any other transactions or trading activity in connection with the
Programme with persons located in the United States of America.
The Mandate does not specify as to how the R7 billion (c.£350 million) will
be deployed across the various share registers. The Mandate will commence on
Monday, 21 November 2022 and will end on or before 31 March 2023.
The repurchased Investec Limited shares will be cancelled and reinstated as
authorised but unissued shares in the share capital of Investec Limited. The
purchased Investec plc shares will be treated as if they were treasury shares
in the consolidated annual financial statements of the Investec Group.
Investec Limited has elected to waive voting and dividend rights of the
purchased Investec plc shares unless notified otherwise.
For further information please contact:
Investec Investor Relations
General enquiries: investorrelations@investec.co.za
(mailto:investorrelations@investec.co.za)
Results:
Qaqambile
Dwayi
Carly Newton
SA Tel: +27 (0)83 457 2134
UK Tel: +44 (0)20
75974493
21 November 2022
Johannesburg and London
JSE Equity Sponsor:
Investec Bank Limited
Forward-looking Statements
This announcement contains forward-looking statements. By their nature, all
forward-looking statements involve risk and uncertainty because they relate to
future events and circumstances which are beyond Investec plc's and Investec
Limited's control. These forward-looking statements speak only as of the date
on which they are made. Investec plc and Investec Limited expressly disclaim
any obligation or undertaking to release publicly any updates or revisions to
any forward-looking statements contained in this announcement or any other
forward-looking statements they may make.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCDZMZMNMMGZZG